Expertise & Training
Timothy Eberlein, MD
2 minsSiteman Cancer Center Director and Washington University surgeon Timothy Eberlein, MD, discusses what breast cancer patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Eberlein: https://siteman.wustl.edu/doctor/eberlein-timothy/
Learn more about the Siteman Approach to Breast Cancer: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/our-approach/
Learn more about all breast cancer treatment options at Siteman Cancer Center: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/treatments/
Hear from Siteman patients who discuss their journey with breast cancer diagnosis, treatment and recovery: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/patient-stories/
Clinical Expertise
As director of the Siteman Cancer Center and a Washington University surgeon, Dr. Eberlein oversees the clinical, research and educational endeavors of Washington University. Dr. Eberlein is a member of our breast cancer specialist team and cares for patients diagnosed with breast cancer through treatment and recovery.
Primary Academic Title
Director, Alvin J. Siteman Cancer Center, Spencer T. and Ann W. Olin Distinguished Professor, WashU Medicine
Board Certification
- 1987: American Board of Surgery, General Surgery
- 1995: American Board of Surgery, General Surgery
- 2007: American Board of Surgery, General Surgery
Training
- 1977 - 1979: Intern and Resident, Surgery, Peter Bent Brigham Hospital, Boston, MA
- 1979 - 1982: Research Fellow, Surgery Branch, National Cancer Institute, Bethesda, MD
- 1982 - 1984: Resident and Chief Resident, Surgery, Brigham and Women's Hospital, Boston, MA
- 1985: Chief Resident, Surgery, Brockton/West Roxbury Veteran's Administration Hospital, Boston, MA
Education
- 1977: MD, University of Pittsburgh, Pittsburgh, PA
Research & Selected Publications
Research Interest
Identification of tumor antigens; study of antigen presentation pathways and co-stimulatory factors; design of a novel vaccine using already obtained unique solid tumor antigens; strategies in the treatment of breast, ovarian and pancreatic cancers; clinical trials involving various biologies in the treatment of solid tumors; murine congenic model to study the mechanism of immune therapies toward developing better treatment strategies.
Research Publications